Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.750
+0.110 (6.71%)
At close: May 12, 2025, 4:00 PM
2.020
+0.270 (15.43%)
After-hours: May 12, 2025, 7:59 PM EDT
BDTX Market Cap
BDTX has a market cap or net worth of $99.18 million as of May 12, 2025. Its market cap has decreased by -63.05% in one year.
Market Cap
99.18M
Enterprise Value
22.80M
1-Year Change
-63.05%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $99.18M, a decrease of -92.68%. That is a compound annual growth rate of -39.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 99.18M | -18.09% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | 1.15B | -14.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |